Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab
NCT00139841
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
103
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG:
Bendamustine HCl
Sponsor
Cephalon